Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

National Institutes of Health

Federal funding opportunity PAR-25-024 published by National Institutes of Health. Review the official synopsis for eligibility, award terms, and application requirements.